Avelumab: Phase III started

Merck and Pfizer began the open-label, international Phase III JAVELIN Renal 101 trial to compare 10 mg/kg IV avelumab every 2 weeks plus twice-daily oral Inlyta axitinib vs. oral Sutent sunitinib a...